Overview
- •
In addition to liver involvement, includes congenital cardiac disease (97%), dysmorphic face (96%), ocular abnormalities (78%), vertebral anomalies (51%), and kidney malformation (40%).
- •
Disease ranges from mild cholestasis to progressive liver failure.
- •
Liver involvement results in the loss of intralobar ducts over months to years.
- •
Elevated serum bile acids, conjugated bilirubin, alkaline phosphatase, and GGT typically seen.
- •
Malnutrition and growth failure is common, leading to delayed pubertal development.
- •
Malnutrition may lead to protuberant abdomen, making pts more prone to regurgitation.
- •
Ineffective absorption of dietary lipids, essential fatty acids, fat-soluble vitamins.
- •
Vitamin deficiencies: vitamin K (coagulopathy), vitamin D (rickets), vitamin E/A (retinopathy and neuropathy).
- •
Vitamin K deficiency and liver dysfunction lead to prolonged PT and PTT as well as thrombocytopenia.
- •
Cardiac abnormalities: Pulm vascular stenosis (most common with up 90% pts), tetralogy of Fallot, truncus arteriosus, patent ductus arteriosus, VSDs.
- •
Facial characteristics: Prominent forehead, hypertelorism, saddle or straight nose.
- •
Vertebral anomalies: Butterfly vertebrae (splitting of the bodies sagittally), spina bifida, fusion of adjacent vertebrae.
- •
Ocular abnormalities: Posterior embryotoxon, microcornea, macular dystrophy.
- •
Posterior embryotoxon progresses to glaucoma in 50% of pts.
- •
Neurologic effects: Cerebellar ataxia and peripheral neuropathy usually due to vitamin E and A deficiency. Mental retardation is also associated with the syndrome.
- •
There is a 12–14% risk of spontaneous intracranial bleed.
- •
Renal dysplasia found in 40% of pts.
- •
Halothane should be avoided as it has a myocardial depressant effect, lowering hepatic blood flow.
- •
Perfusion pressure to liver and kidney should be maintained with periop hydration and blood pressure control.